
Nivolumab immunotherapy safe, feasible during chemoradiation for advanced head and neck cancer
Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered…
Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered…